Skip to main content

Table 1 Demographic characteristics

From: The ratio of monocytes to lymphocytes multiplying platelet predicts incidence of pulmonary infection-related acute kidney injury

Variables

AKI (n = 177)

non-AKI (n = 764)

Total (n = 941)

AKI

Severe AKI

OR (95%CI)

P

OR (95%CI)

P

Demographic characteristics

 Age

73.67 ± 15.19

63.37 ± 16.25

65.31 ± 16.55

1.05 (1.03–1.06)

 < 0.001

1.04 (1.03–1.06)

 < 0.001

 Male gender, n (%)

133 (75.1)

500 (65.4)

633 (67.3)

1.59 (1.09–2.35)

0.019

1.50 (0.91–2.58)

0.127

 BMI(kg/m2)

22.55 ± 3.58

22.09 ± 3.80

22.18 ± 3.76

1.04 (0.99–1.08)

0.130

1.01 (0.95–1.07)

0.773

Comorbidities

 Hypertension, n (%)

65 (21.3)

240 (78.7)

305 (100.0)

0.79 (0.54–1.15)

0.222

0.84 (0.50–1.36)

0.480

 Diabetes mellitus, n (%)

29 (20.7)

111 (79.3)

140 (100.0)

0.96 (0.59–1.51)

0.848

0.72 (0.34–1.37)

0.345

 Coronary heart disease, n (%)

53 (32.7)

109 (67.3)

162 (100.0)

1.66 (1.10–2.48)

0.015

1.68 (0.97–2.85)

0.060

 Stroke, n (%)

35 (33.3)

70 (66.7)

105 (100.0)

1.70 (1.05–2.70)

0.027

1.93 (1.03–3.48)

0.033

 CKD, n (%)

84 (51.5)

79 (48.5)

163 (100.0)

6.30 (4.22–9.45)

 < 0.001

5.04 (2.97–8.52)

 < 0.001

 Malignancy, n (%)

43 (18.4)

191 (81.6)

234 (100.0)

1.06 (0.70–1.57)

0.787

1.20 (0.69–2.02)

0.505

Treatment

 Emergency, n (%)

94 (24.9)

283 (75.1)

377 (100.0)

1.63 (1.16–2.31)

0.005

1.67 (1.05–2.67)

0.030

 Surgery, n (%)

31 (25.0)

93 (75.0)

124 (100.0)

1.63 (1.01–2.57)

0.041

1.44 (0.72–2.69)

0.274

 Nephrotoxic drug, n (%)

136 (24.5)

418 (75.5)

554 (100.0)

2.79 (1.90–4.17)

 < 0.001

2.50 (1.50–4.29)

 < 0.001

  1. OR values for age, gender, and BMI were calculated in univariate model, and the rest OR values of comorbidities and treatment were adjusted for age, sex and BMI
  2. BMI body mass index, CKD chronic kidney disease